HCID 22813385, compound → HCID 22813387, compound
Reaction equation
[CH:1]1[C:9]2[C@H:10]3[O:15][CH2:14][CH2:13][NH:12][C@@H:11]3[CH2:16][C:7]3[C:8]=2[C:4]([NH:5][CH:6]=3)=[CH:3][CH:2]=1>[Pd].C(O)C>[CH2:9]([N:12]1[C@@H:11]2[CH2:16][C:7]3[C:8]4[C:4]([NH:5][CH:6]=3)=[CH:3][CH:2]=[CH:1][C:9]=4[C@H:10]2[O:15][CH2:14][CH2:13]1)[CH2:1][CH2:2][CH3:3]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A suspension of trans-4,6,6a,8,9,10a-hexahydro-7H-indolo-[3,4 gh]-[1,4]-benzoxazine (700 mg; 0.0032 m), Pd/c (10%, 700 mg) and butrylaldehyde (500 mg, 0.006 m) in abs. ethanol (75 ml) is hydrogenated at room temperature for 8 hours. The catalyst is filtered, and the solvent is removed under reduced pressure (20 mm). The resulting oil is chromatographed (silica, chloroform, saturated with aqueous ammonia). The solid is recrystallized from hexane to yield 250 mg of trans-4,6,6a,8,9,10a-hexahydro-7-n-butyl-7H-indolo-[3,4 gh]-[1,4]-benzoxazine; m.p. softens 29°-130°, m.p. 134°-140°.
Workup
- filtrationThe catalyst is filtered
- customthe solvent is removed under reduced pressure (20 mm)
- customThe resulting oil is chromatographed (silica, chloroform, saturated with aqueous ammonia)
- customThe solid is recrystallized from hexane
Sources & evidence
- ORD record
- ord-d840c0e5a50f4ca584c625adaafa2eaa
- Source dataset
- uspto-grants-1980_12
- Patent number
- US04238486
Reaction notes
Loading…